|
Hokkaido University Collection of Scholarly and Academic Papers >
Hokkaido University Hospital >
Peer-reviewed Journal Articles, etc >
Decreased electrodermal activity in patients with epilepsy
This item is licensed under:Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International
| Title: | Decreased electrodermal activity in patients with epilepsy |
| Authors: | Horinouchi, Toru Browse this author →KAKEN DB | | Sakurai, Kotaro Browse this author | | Munekata, Nagisa Browse this author | | Kurita, Tsugiko Browse this author | | Takeda, Youji Browse this author | | Kusumi, Ichiro Browse this author →KAKEN DB |
| Keywords: | Electrodennal activity | | Biofeedback therapy | | Seizure numbers | | Noninvasive | | Galvanic skin response | | Intractable epilepsy |
| Issue Date: | Nov-2019 |
| Publisher: | Elsevier |
| Journal Title: | Epilepsy and behavior |
| Volume: | 100 |
| Start Page: | UNSP 106517 |
| Publisher DOI: | 10.1016/j.yebeh.2019.106517 |
| Abstract: | Objective: Biofeedback therapy using electrodermal activity (EDA) is a new noninvasive therapy for intractable epilepsy. However, the characteristics of EDA in patients with epilepsy are little known; therefore, we assessed the EDA characteristics in patients with epilepsy. Methods: A cross-sectional observational study was conducted in 22 patients with epilepsy and 24 healthy individuals. We collected information on demographic characteristics, EDA, and state anxiety from both groups, and epilepsy diagnosis, seizure number per month, disease duration, and number of antiepileptic drugs (AED) from the epilepsy group. A wristband device was used to measure resting EDA from both wrists for 10 min under controlled temperature and humidity. We compared the EDA levels between the epilepsy group and the control group and examined correlations between EDA and epilepsy-associated factors in the epilepsy group. Results: A decreasing trend in EDA was observed during the first 1 min from the start of the measurement in 22 patients with epilepsy (with or without seizures) compared with healthy controls (P = 0.12). However, a significant decrease in EDA was found in 18 patients with epilepsy with seizures compared with healthy controls (- 0.48 versus -0.26; P = 0.036). Furthermore, seizure frequency showed a significant inverse correlation with EDA in the epilepsy group (p =-0.50, P = 0.016). However, neither disease duration nor the number of drugs prescribed correlated with EDA in the epilepsy group. Significance: Marginally decreased EDA was observed in patients with epilepsy, and significantly decreased EDA was found in patients with a higher seizure frequency. The present findings shed light on the appropriateness of EDA-biofeedback therapy in epilepsy. (C) 2019 Elsevier Inc. All rights reserved. |
| Rights: | © 2019. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/ | | http://creativecommons.org/licenses/by-nc-nd/4.0/ |
| Type: | article (author version) |
| URI: | http://hdl.handle.net/2115/79653 |
| Appears in Collections: | 北海道大学病院 (Hokkaido University Hospital) > 雑誌発表論文等 (Peer-reviewed Journal Articles, etc)
|
Submitter: 堀之内 徹
|
